These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2955843)

  • 21. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
    Linnik MD; Butler BT; Gaddis RR; Ahmed NK
    J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
    Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
    J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of metoclopramide and zetidoline on gastrointestinal motility.
    Lobbezoo MW; Janszen FH; Tulp MT; Zwagemakers JM
    Eur J Pharmacol; 1985 Jan; 108(2):105-12. PubMed ID: 3979439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric emptying and subjective symptoms of nausea: lack of effects of a 5-hydroxytryptamine-3 antagonist ondansetron on gastric emptying in patients with gastric stasis syndrome.
    Nielsen OH; Hvid-Jacobsen K; Lund P; Langholz E
    Digestion; 1990; 46(2):89-96. PubMed ID: 2147664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
    Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
    Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting.
    Grunberg SM; Stevenson LL; Russell CA; McDermed JE
    J Clin Oncol; 1989 Aug; 7(8):1137-41. PubMed ID: 2526864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological properties of quinoxaline derivatives as a new class of 5-HT3 receptor antagonists.
    Lasheras B; Berjón A; Montañés R; Roca J; Romero G; Ramírez MJ; Del Río J
    Arzneimittelforschung; 1996 Apr; 46(4):401-6. PubMed ID: 8740088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of cisapride, metoclopramide and loperamide on gastric emptying of normal volunteers as measured by means of the area under the curve of the cumulative fraction absorbed-time profiles of paracetamol.
    van Wyk M; Sommers DK; Moncrieff J
    Methods Find Exp Clin Pharmacol; 1992 Jun; 14(5):379-82. PubMed ID: 1513194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects.
    Akkermans LM; Vos A; Hoekstra A; Roelofs JM; Horowitz M
    Gut; 1988 Sep; 29(9):1249-52. PubMed ID: 3198000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The action of dazopride to enhance gastric emptying and block emesis.
    Costall B; Domeney AM; Gunning SJ; Kelly ME; Naylor RJ; Nohria V; Owera-Atepo JB; Simpson KM; Tan CC; Tattersall D
    Neuropharmacology; 1987 Jul; 26(7A):669-77. PubMed ID: 3114664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
    Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
    Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
    [No Abstract]   [Full Text] [Related]  

  • 34. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
    Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the 5-HT3 receptor antagonist ICS 205-930 on fat-delayed gastric emptying and antral motor activity.
    Stacher G; Bergmann H; Schneider C; Steiner-Mittelbach G; Gaupmann G; Steinringer H; Abatzi TA; Stacher-Janotta G
    Br J Clin Pharmacol; 1990 Jul; 30(1):41-8. PubMed ID: 2390431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
    Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB
    Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea pig proximal colon in vitro?
    Sevcík J; Ruzicka V; Slánsky J; Masek K
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):421-30. PubMed ID: 8900213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dopamine and alpha-adrenoreceptors in the control of gastric emptying in the rat: possible involvement in the mechanism of action of metoclopramide.
    Cooper SM; McRitchie B
    J Auton Pharmacol; 1985 Dec; 5(4):325-31. PubMed ID: 2869043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
    Yoshikawa T; Yoshida N; Oka M
    Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An examination of the 5-HT3 receptor mediating contraction and evoked [3H]-acetylcholine release in the guinea-pig ileum.
    Fox A; Morton IK
    Br J Pharmacol; 1990 Nov; 101(3):553-8. PubMed ID: 2150179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.